RDC Stock Financial Analysis - Redcare Pharmacy NV (XTRA) Stock

Overview

Redcare Pharmacy NV is a company based in the Netherlands, primarily operating within the pharmaceutical sector. It specializes in retailing a wide range of medications and health-related products, and also offers pharmaceutical services to customers. Key projects typically involve leveraging advanced technology to improve the efficiency of their service delivery and expanding their reach through e-commerce platforms. These initiatives aim to enhance customer accessibility to pharmaceutical services and cater to the growing demand for health products. Redcare Pharmacy NV continuously focuses on integrating innovative solutions that optimize operational efficiency and customer satisfaction, sustaining its competitive edge in the fast-evolving healthcare market.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Redcare Pharmacy NV as of 30 June 2025 is 2,676.16 MM.
The operating income for Redcare Pharmacy NV as of 30 June 2025 is -34.95 MM.
The net income for Redcare Pharmacy NV as of 30 June 2025 is -34.86 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	2,676.16	-34.95	-34.86
2025-03-31	2,527.64	-37.98	-48.48
2024-12-31	2,370.57	-34.95	-45.46
2024-09-30	2,226.76	-14.53	-24.56
2024-06-30	2,127.71	-7.66	-9.33
2024-03-31	1,986.92	-4.46	-9.62
2023-12-31	1,798.76	-3.79	-12.04
2023-09-30	1,595.27	-8.17	-16.23
2023-06-30	1,404.29	-10.74	-44.67
2023-03-31	1,271.62	-39.12	-64.94
2022-12-31	1,204.35	-47.23	-77.65
2022-09-30	1,164.55	-56.28	-110.36
2022-06-30	1,117.88	-67.69	-104.98
2022-03-31	1,081.05	-45.32	-91.33
2021-12-31	1,060.32	-32.25	-74.19
2021-09-30	1,037.01	-18.19	-39.01
2021-06-30	1,037.84	-4.47	-28.61
2021-03-31	1,020.13	4.13	-17.60
2020-12-31	968.06	5.56	-16.77
2020-09-30	895.20	1.50	-15.32
2020-06-30

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	-2.27	-2.27
2024-09-30
2024-06-30	-0.47	-0.47
2024-03-31
2023-12-31	-0.63	-0.63
2023-09-30
2023-06-30	-2.45	-2.45
2023-03-31
2022-12-31	-4.32	-4.32
2022-09-30
2022-06-30	-5.81	-5.81
2022-03-31
2021-12-31	-4.15
2021-09-30
2021-06-30	-1.75	-1.75
2021-03-31
2020-12-31	-1.17
2020-09-30
2020-06-30	-1.46	-1.46

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Redcare Pharmacy NV as of 30 June 2025 is 43.81 MM.
The cash from investing activities for Redcare Pharmacy NV as of 30 June 2025 is -178.67 MM.
The cash from financing activities for Redcare Pharmacy NV as of 30 June 2025 is 117.35 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	43.81	-178.67	117.35
2025-03-31	38.13	-9.32	-24.18
2024-12-31	22.13	8.38	-17.94
2024-09-30	31.00	-65.63	-18.73
2024-06-30	32.59	-34.87	-17.52
2024-03-31	38.41	-53.01	14.80
2023-12-31	61.46	-59.96	15.05
2023-09-30	40.17	-18.95	15.32
2023-06-30	33.41	-144.09	14.82
2023-03-31	-8.96	-135.56	-14.02
2022-12-31	-29.11	-138.01	-13.52
2022-09-30	-16.42	-135.99	-12.40
2022-06-30	1.25	-53.15	-12.60
2022-03-31	5.67	-41.91	-9.94
2021-12-31	11.63	-84.30	229.59
2021-09-30	35.24	-88.36	216.42
2021-06-30	26.94	-93.53	242.90
2021-03-31	35.46	-87.94	287.78
2020-12-31	17.80	-40.16	50.19
2020-09-30	-19.15	-23.73	66.05
2020-06-30

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for Redcare Pharmacy NV as of 30 June 2025 is -39.36.
The p/book for Redcare Pharmacy NV as of 30 June 2025 is 3.87.
The p/tbv for Redcare Pharmacy NV as of 30 June 2025 is 28.61.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30	-39.36	3.87	28.61
2025-03-31	-53.60	4.78	24.70
2024-12-31	-109.89	5.05	22.43
2024-09-30	-292.29	5.06	22.56
2024-06-30	-246.04	4.36	-15.08
2024-03-31	-250.00	5.45	24.29
2023-12-31	-149.44	3.86	19.00
2023-09-30
2023-06-30
2023-03-31	-28.25	5.28	-16.52
2022-12-31	-15.46	4.73	31.91
2022-09-30	-16.53	5.05	34.11
2022-06-30	-17.37	4.85	-22.65
2022-03-31	-19.97	4.60	-98.49
2021-12-31	-24.59	4.39	11.55
2021-09-30	-46.75	4.04	11.74
2021-06-30	-63.75	3.93	41.58
2021-03-31	-102.70	3.83	30.59
2020-12-31	-107.80	4.25	8.20
2020-09-30	-98.98	5.04	16.12
2020-06-30	-75.58	5.07	-45.95

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Redcare Pharmacy NV as of 30 June 2025 is -0.02.
The ebit (3y)/ev for Redcare Pharmacy NV as of 30 June 2025 is -0.02.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	-0.02	-0.02
2025-03-31	-0.02	-0.02
2024-12-31	-0.01	-0.01
2024-09-30	-0.00	-0.02
2024-06-30	-0.00	-0.02
2024-03-31	-0.00	-0.02
2023-12-31	-0.01	-0.02
2023-09-30	-0.03	-0.03
2023-06-30
2023-03-31	-0.04	-0.03
2022-12-31	-0.06	-0.03
2022-09-30	-0.06	-0.03
2022-06-30	-0.06	-0.03
2022-03-31	-0.05	-0.03
2021-12-31	-0.04	-0.03
2021-09-30	-0.02	-0.02
2021-06-30	-0.02	-0.02
2021-03-31	-0.01	-0.02
2020-12-31	-0.01	-0.02
2020-09-30	-0.01	-0.02
2020-06-30	-0.02	-0.02

Management Effectiveness

The roa for Redcare Pharmacy NV as of 30 June 2025 is -0.05.
The roe for Redcare Pharmacy NV as of 30 June 2025 is -0.09.
The roic for Redcare Pharmacy NV as of 30 June 2025 is -0.06.
The croic for Redcare Pharmacy NV as of 30 June 2025 is 0.01.
The ocroic for Redcare Pharmacy NV as of 30 June 2025 is 0.05.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	-0.05	-0.09	-0.06	0.01	0.05
2025-03-31	-0.04	-0.08	-0.06	0.02	0.03
2024-12-31	-0.02	-0.08	-0.03	-0.07	0.04
2024-09-30	-0.01	-0.04	-0.01	-0.02	0.04
2024-06-30	-0.01	-0.03	-0.01	0.00	0.05
2024-03-31	-0.02	-0.03	-0.02	0.02	0.08
2023-12-31	-0.02	-0.04	-0.02	0.04	0.05
2023-09-30	-0.06	-0.12	-0.05	-0.11	0.04
2023-06-30		-0.12	-0.07	-0.15
2023-03-31	-0.08	-0.16	-0.10	-0.25	-0.01
2022-12-31	-0.14	-0.24	-0.17	-0.26	-0.03
2022-09-30	-0.14	-0.24	-0.17	-0.26	-0.03
2022-06-30	-0.13	-0.23	-0.16	-0.10	0.00
2022-03-31	-0.11	-0.19	-0.14	-0.07	0.01
2021-12-31	-0.14	-0.17	-0.12	0.24	0.02
2021-09-30	-0.07	-0.13	-0.05	0.23	0.05
2021-06-30	-0.05	-0.10	-0.04	0.23	0.04
2021-03-31	-0.04	-0.08	-0.02	0.31	0.05
2020-12-31	-0.04	-0.07	-0.04	0.06	0.04
2020-09-30	-0.03	-0.06	-0.03	0.05	-0.02
2020-06-30	-0.04	-0.08	-0.04	0.01	-0.06

Gross Margins

The gross margin for Redcare Pharmacy NV as of 30 June 2025 is 0.23.
The net margin for Redcare Pharmacy NV as of 30 June 2025 is -0.02.
The operating margin for Redcare Pharmacy NV as of 30 June 2025 is -0.02.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.23	-0.02	-0.02
2025-03-31	0.23	-0.02	-0.01
2024-12-31	0.23	-0.01	-0.01
2024-09-30	0.23	-0.00	-0.00
2024-06-30	0.24	-0.00	-0.00
2024-03-31	0.24	-0.01	-0.00
2023-12-31	0.26	-0.01	-0.01
2023-09-30	0.27	-0.03	-0.01
2023-06-30		-0.03	-0.01
2023-03-31	0.28	-0.05	-0.03
2022-12-31	0.27	-0.09	-0.05
2022-09-30	0.27	-0.09	-0.05
2022-06-30	0.26	-0.09	-0.05
2022-03-31	0.25	-0.08	-0.04
2021-12-31	0.25	-0.07	-0.03
2021-09-30	0.25	-0.04	-0.01
2021-06-30	0.24	-0.03	-0.00
2021-03-31	0.24	-0.02	0.00
2020-12-31	0.23	-0.02	0.01
2020-09-30	0.22	-0.02	-0.00
2020-06-30	0.21	-0.02	-0.02

US:SHPPF
IT:1RDC	108,20 €
GB:0RJT
GB:RDCD
AT:SHOP